Alemtuzumab Reduces Relapses, Prevents Accumulation of Disability Compared With Standard Therapy:
Presented at ECTRIMS
PRAGUE, CZECH REPUBLIC
Early treatment with alemtuzumab -- a ... more »
|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Tuesday, November 27
Alemtuzumab Reduces Relapses, Prevents Accumulation of Disability Compared With Standard Therapy
by
All About MS
on Tue 27 Nov 2007 12:00 AM CST
|
||